Human Genome Sciences Stock Price and Value Analysis
Should you buy Human Genome Sciences stock? (NASDAQ:HGSI). Let's see how it does in our automated value investing analysis system.
Advantages | Disadvantages | Neutral |
---|---|---|
None. |
|
|
Inside the HGSI Numbers
HGSI Price (Human Genome Sciences stock price per share) |
$14.24 | |
[?]
|
PE Ratio versus Sector | 100% lower than other Unknown stocks |
[?]
|
PE Ratio versus Industry | 100% lower than other Unknown stocks |
[?]
|
Cash Yield | -14.64% |
[?]
|
Free Cash Flow Jitter | 43% |
Is Human Genome Sciences Stock on Sale?
Based on our analysis, we believe that you should not buy Human Genome Sciences right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.
Should You Buy HGSI Stock?
Does Human Genome Sciences have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.